![Steven Axon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Axon
Director Ejecutivo en
Glycomine, Inc.
.
Perfil
Steven Jon Axon is currently Chief Executive Officer & Director at Glycomine, Inc. since 2022.
Mr. Axon is also a Director at Metronet (UK) Ltd. since 2016.
Additionally, Mr. Axon serves as an Independent Director at Complement Therapeutics Ltd. starting in 2022.
Former roles include Chief Business Officer at Apellis Pharmaceuticals, Inc., Head-Business Development at EMD Serono, Inc. from 2005 to 2014, and Principal at Accenture LLC.
Education includes undergraduate and graduate degrees from the University of Toronto and an MBA from the International Institute for Management Development.
Cargos activos de Steven Axon
| Empresas | Cargo | Inicio |
|---|---|---|
Metronet (UK) Ltd.
 Metronet (UK) Ltd. Data Processing ServicesTechnology Services Provides cloud, datacenter and backup services | Director/Miembro de la Junta | 22/03/2016 |
Complement Therapeutics Ltd.
 Complement Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops complement medicines | Director/Miembro de la Junta | 01/05/2022 |
Glycomine, Inc.
 Glycomine, Inc. BiotechnologyHealth Technology Develops replacement therapies for rare genetic diseases | Director Ejecutivo | 01/06/2022 |
Antiguos cargos conocidos de Steven Axon.
| Empresas | Cargo | Fin |
|---|---|---|
Accenture LLC
 Accenture LLC Miscellaneous Commercial ServicesCommercial Services Provides financial and investment services | Corporate Officer/Principal | - |
| APELLIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
EMD Serono, Inc.
 EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Corporate Officer/Principal | - |
Formación de Steven Axon.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
17
Relaciones de 1er grado
8
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 8 |
|---|---|
Apellis Pharmaceuticals, Inc.
 Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. BiotechnologyHealth Technology Develops therapeutics and drug delivery devices for neurology, oncology & immunology | Health Technology |
International Institute for Management Development
 International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Metronet (UK) Ltd.
Metronet (UK) Ltd. Data Processing ServicesTechnology Services Provides cloud, datacenter and backup services | Technology Services |
Accenture LLC
Accenture LLC Miscellaneous Commercial ServicesCommercial Services Provides financial and investment services | Commercial Services |
Glycomine, Inc.
Glycomine, Inc. BiotechnologyHealth Technology Develops replacement therapies for rare genetic diseases | Health Technology |
Complement Therapeutics Ltd.
Complement Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops complement medicines | Health Technology |
- Bolsa de valores
- Insiders
- Steven Axon
